Static

A New Benchmark for De-Aging Comes From Slowly Turning Back Cells’ Clocks

First reported by Wired ·

The signal ●○○○ Compiled by AI from Wired, the single source so far
Why you might care

The ability to measure cellular age reversal offers a reliable benchmark for future de-aging therapies and research into age-related diseases.

What happened

Researchers at Bonn University in Germany have developed a new method for de-aging cells without fully reverting them to a pluripotent state, a process that carries cancer risks. The team, led by Oliver Brüstle, took blood cells from donors of various ages and reprogrammed them into a younger state. Crucially, they did not push the cells all the way to becoming embryonic-like stem cells. During this partial reprogramming, conducted over less than two months, one biomarker indicating a cell's age reversed by as much as 60 years. This rejuvenation effect persisted even when the cells' ability to multiply was significantly reduced, suggesting the reversal is not solely due to cell division. While the exact mechanism behind this de-aging remains unclear, the study tracked the process step-by-step, offering new insights into cellular rejuvenation. The researchers also successfully shifted blood cells into neuron-like cells, a potential application for regenerative medicine.

What it means

This research signals a potential shift in de-aging strategies by exploring partial cellular reprogramming, which avoids the oncogenic risks associated with full pluripotency. By dissecting the de-aging process over time, scientists can now investigate the underlying mechanisms, paving the way for more targeted interventions. This could dramatically impact regenerative medicine, offering new ways to combat age-related cellular damage and disease.

The study's novelty lies in its ability to provide a tractable model for observing cellular rejuvenation, a process previously understood only as an instantaneous event. This detailed observation of 'how' cells shed age markers, rather than just 'that' they do, empowers researchers to test numerous variables affecting de-aging. Such granular understanding is critical for developing clinical applications that reliably reverse aging at a cellular level, moving beyond current, less precise methods.

AI-written summary. May contain errors.

Benchmark